DACT1, an antagonist to Wnt/beta-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Introduction: Aberrant activation of Wnt/beta-catenin signaling plays an important role in the pathogenesis of breast cancer. DACT1 (Dapper/Frodo) has been identified as involved in antagonizing Wnt/beta-catenin signaling through interacting with Dishevelled (Dvl), a central mediator of Wnt signaling, whereas its role in breast tumorigenesis remains unclear.
著者Yin XD, Xiang TX, Li LL, Su XW, Shu XS, Luo XR, Huang JB, Yuan Y, Peng WY, Oberst M, Kelly K, Ren GS, Tao Q
期刊名稱Breast Cancer Research
出版年份2013
月份1
日期1
卷號15
期次2
出版社BIOMED CENTRAL LTD
國際標準期刊號1465-5411
電子國際標準期刊號1465-5411
語言英式英語
Web of Science 學科類別Oncology; ONCOLOGY

上次更新時間 2020-05-12 於 00:10